• A novel complex of Zn(II) has been synthesized through a one-pot reaction and without using chemical solvents • The structure of the complex was characterized by X-ray crystallography • In vitro cytotoxicity of the compounds was studied against four cancer cell lines and a normal cell line • Effect of the complex was assayed on production of ROS and decrease of MMP in A375 and HT29 cells • In vitro antimicrobial activity of the compounds was tested A zinc(II) complex formulated as (4-apyH) 2 [Zn(pydc)(pydcH)] 2 .(pydcH 2 ) 2 .10H 2 O was prepared through a one-pot reaction of pyridine-2,6- dicarboxylic acid, 4-aminopyridine, and zinc chloride anhydrous metal salt. In all the steps, only distilled water was used as the solvent. The compound was fully characterized by single-crystal X-ray diffraction and disordered octahedral geometry was recognized for it. The cytotoxicity of the complex and its ligands was evaluated by MTT method against A375, LN229, DLD1, HT29, and HFF cell lines. The strongest anti-proliferative effect of the complex was exhibited toward HT29 (IC 50 =10 µM, Viability inhibition =78.23%) cells. The apoptosis was proposed as the main pathway for the death of the cells according to the product of ROS high value and reduction of MMP. The antibacterial effect of compounds was studied against two Gram-positive bacteria namely Staphylococcus aureus , and Staphylococcus epidermidis, and also three Gram-negative bacteria namely Escherichia coli, Pseudomonas aeruginosa, and Proteus vulgaris . The established antibacterial tests were including the broth microdilution method and the agar well diffusion method. S. aureus (MIC=16 µg/mL, IZD=30 mm) and S. epidermidis (MIC=32 µg/mL, IZD=22 mm) were considered as the most susceptible bacteria following treatment of the complex. A new Zn(II) complex was synthesized without using chemical solvents and was characterized by single-crystal X-ray diffraction. Anticancer activity of the complex, ligands, and zinc chloride anhydrous metal salt was evaluated by MTT assay toward A375, LN229, DLD1, HT29, and HFF cells. The strongest cytotoxic effect was indicated by the complex toward A375 and HT29 cells, in vitro . Accordingly, these two cell lines were selected to evaluate MMP and ROS. Also, the antimicrobial activity of the compounds was investigated against 5 strains of Gram-negative and Gram-positive bacteria. S. aureus and S. epidermidis were realized as the most susceptible bacteria following the treatment of the complex.